There seem to be all kinds of setups around the world, and some of them will probably generate nice results. This year has certainly been a rollercoaster. At the beginning of the year, the share price was at four euros, followed by a poor Q1 and a rather weak Q2. Then Q3 was really good again. If the pace had been steadier, would the price still be hovering around €4?? Quite a win for AEYE Health with this Prix Galien award as well. Visibility is guaranteed. Personally, I’ve started adding Optomed to my portfolio.
Great spot on this! Aireen (and Optomed) gets an excellent reference from this if everything gets up and running smoothly at Alensa.
And things are buzzing in China… Could it be that the binary is turning into something else (at least that’s what one could deduce from the post’s content… scaling up in primary healthcare in Guangzhou?
Well, if there was one camera for every site, that’d certainly be a good start ![]()
The only ones liking it are Piila and Himberg ![]()
National DR screening is also being moved forward in Nigeria:
yeah, coincidentally just them, I bet we’ll get more info on Monday too.
Here is a little something to explore over the weekend—the 25 largest health screening software companies in the United States:
https://revenuebase.ai/companies/health-screening-software-companies/united-states\
What, why, and from where is information expected to come on Monday?
Hardly likely we’ll hear anything from China for a while, and Wiser will communicate if they communicate.
Here are more facts on the strong strategic targeting of the primary healthcare field from Aeye Health’s partner:
And developments in Finland as well
Based on the pictures, Lumo was involved in PSMMC’s DR campaign. PSMMC, or Prince Sultan Military Medical City, is a large public hospital complex located in Riyadh, Saudi Arabia. If I recall correctly, Himberg once mentioned regarding the Middle East that if any deals happen there, they will be larger ones.
Quite a lot of activity all of a sudden around the globe…. And HLTH USA has just begun with AEYE Health attending, interesting times
So they’ve now completed the proof of concept there and verified that the system works as it should.
Next up is scaling across the entire Guangdong province. And most likely kicking off operations in other provinces as well. That is, after all, the whole purpose of the Charm Alliance. And right from the start, Charm Alliance already had over a hundred hospitals involved across China. ![]()
Is it time to post this yet
?
I bet that a board chairman with signing authority isn’t flown out there just for fun. That pen will probably see some use. Wild guess: six months ago, a pilot agreement was signed, and now … perhaps something else.
Looking at today’s price action, you’d think someone knows what has been signed![]()
It strongly smells like things are progressing according to plan, even though nothing was breathed about this in the interim report.
Maybe, but I’d like to remind everyone of the reality that, just as you couldn’t deduce that the company’s business was tanking when the stock dropped due to Finnish funds selling, you can’t conclude from the current buying frenzy that any significant company milestones have been reached.
Website of the CHARM alliance, mentioned in Wiser’s summer press release:
Guangzhou Oushi Medical appears to be a distribution/solution company linked to Optomed
Chinese company registers list <广州欧视医疗科技有限公司>. 19.9% of its ownership belongs to Optomed.
Updated link: https://www.qcc.com/firm/f7a83617c0e8ed8118224e4d9882b0d8.html
The company markets:
- handheld fundus cameras
- AI screening solutions
- cloud-based screening and monitoring systems
This is interesting because Guangzhou’s public screening projects simultaneously feature:
- EVisionAI (analytics)
- Oushi Medical (device supplier)
- Guangzhou health authorities [[zhuanlan.zhihu.com]]
This was in August. People had already been recruited back then
